[Company Logo Image] Compound validation and profiling in vitro and in vivo
Improved clinical predictability of preclinical studies
Subcutaneous and orthotopic human xenografts
Genetically modified organ specific tumour models
Receptor tyrosine kinase-driven breast cancer model

         Preclinical Concept Validation

Angiogenesis in vivo Model

       

Syngeneic tumour models
Pharmacokinetic studies
  Toxicology (GLP)
  Histology (Frozen Sections and Paraffin Embedded Sections)

                      

Home vivoPharm Search Employment Feedback

Up R&D News Services Management

 


What's New?

  • The Trade Mark "vivoPharm" was granted (17/12/03)
     
  • A Bone Metastases model was added to the panel of animal models, breast tumour cells are injected into the tibia channel to mimic bone metastases (26/11/2003)
     
  • vivoPharm extends its service: We provide you with frozen or paraffin embedded section of the tumour and the end point of efficacy studies. Furthermore, we also provide immunohistochemical analysis with your preferred antibodies (24/10/03).
     
  • The publication demonstrating  the clinical predictability of vivoPharm's  NeuT-driven syngeneic breast cancer model was awarded by the European Society of Toxicology and Pathology: " ... Especially the correlation of morphology with the results derived from cell proliferation assessment using Laser Scanning Cytometry is of major interest for experimental pathology" (02/10/2003)
    "Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands"  ESTP Seminar Series Roth DR, Roman D, Cozens R, Brandt R, Seewald W, Greiner B, Wegner F, Mamom T, Germann PG (2003) Effects of epithelial growth factor receptor (EGFR) kinase inhibitors on genetically reconstituted mouse mammary glands. Exp Toxicol Pathol in press
     
  •  
  • Syngeneic rat models were added to the panel of animal models (26/09/2003)
     
  • A sophisticated in vivo angiogenesis model was added to the panel of animal models (24/09/2003)


Recent Media Coverage of vivoPharm Pty Ltd

 

   

Send mail to webmaster@vivopharm.com with questions or comments about this web site.
Last modified: 18-Dec-2003